Distinct modulation of superficial and juxtamedullary arterioles by prostaglandin in vivo

Hypertension Research

Volumn 25, Issue 6, 2002, Pages 901-910

  Matsuda, Hiroto ^a   Hayashi, Koichi ^a   Arakawa, Koki ^a   Kubota, Eiji ^a   Honda, Masanori ^a   Tokuyama, Hirobumi ^a   Suzuki, Hiromichi ^b   Yamamoto, Tokunori ^c   Kajiya, Fumihiko ^c   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Afferent arterioles; Angiotensin II; Efferent arterioles; Nitric oxide; Prostaglandin

Indexed keywords

ANGIOTENSIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; PENTOBARBITAL; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY COMPLIANCE; ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL TONE; CONTROLLED STUDY; DOG; EFFERENT NERVE; IN VIVO STUDY; INHIBITION KINETICS; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; KIDNEY CORTEX; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; MALE; MICROCIRCULATION; MICROSCOPY; MICROVASCULATURE; MODULATION; NEPHRON; NONHUMAN; PARACRINE SIGNALING; PROSTAGLANDIN SYNTHESIS; SENSORY NERVE; VASOCONSTRICTION;

EID: 12244252218     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.901     Document Type: Article

References (33)

1. Baylis C, Brenner BM: Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res 1978; 43: 889-898.
2. Carmines PK, Morrison TK, Navar LG: Angiotensin II effects on microvascular diameters of in vitro blood-perfused juxtamedullary nephrons. Am J Physiol 1986; 251: F610-F618.
3. Casellas D, Carmines PK, Navar LG: Microvascular reactivity of in vitro blood perfused juxtamedullary nephrons from rats. Kidney Int 1985; 28: 752-759.
4. Kontogiannis J, Burns KD: Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 1998; 274: F79-F90.
5. Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int 2000; 58(Suppl 77): S93-S98.
6. Keil J, Lehnfeld R, Reinhardt HW, Mohnhaupt R, Kaczmarczyk G: Acute effects of angiotensin II on renal haemodynamics and excretion in conscious dogs. Ren Physiol Biochem 1989; 12: 238-249.
7. Kastner PR, Hall JE, Guyton AC: Control of glomerular filtration rate: role of intrarenally formed angiotensin II. Am J Physiol 1984; 246: F897-F906.
8. Ito S, Johnson CS, Carretero OA: Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991; 87: 1656-1663.
9. Loutzenhiser R, Epstein M, Hayashi K, Takenaka T, Forster H: Characterization of the renal microvascular effects of angiotensin II antagonist, DuP 753: studies in isolated perfused hydronephrotic kidneys. Am J Hypertens 1991; 4: 309S-314S.
10. Hayashi K, Fujiwara K, Oka K, Nagahama T, Matsuda H, Saruta T: Effects of insulin on rat renal microvessels: studies in the isolated perfused hydronephrotic kidney. Kidney Int 1997; 51: 1507-1513.
11. Steinhausen M, Ballantyne D, Fretschner M, Hoffend J, Parekh N: Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin II. Kidney Int 1990; 38 (Suppl 30): S55-S59.
12. Deng X, Welch WJ, Wilcox CS: Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension 1996; 27: 1173-1179.
13. Bugge JF, Stokke ES: Angiotensin II and renal prostaglandin release in the dog: interactions in controlling renal blood flow and glomerular filtration rate. Acta Physiol Scand 1994; 150: 431-440.
14. Inscho EW, Carmines PK, Navar LG: Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Physiol 1990; 259: F157-F163.
15. Matsuda H, Hayashi K, Arakawa K, et al: Zonal heterogeneity in action of angiotensin-converting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin. J Am Soc Nephrol 1999; 10: 2272-2282.
16. Zou AP, Cowley A Jr: Nitric oxide in renal cortex and medulla: an in vivo microdialysis study. Hypertension 1997; 29: 194-198.
17. Itskovitz HD, Terragno NA, McGiff JC: Effect of a renal prostaglandin on distribution of blood flow in the isolated canine kidney. Circ Res 1974; 34: 770-776.
18. Yamamoto T, Hayashi K, Matsuda H, et al: In vivo visualization of tubuloglomerular feedback- and angiotensin II-induced renal vasoconstriction in dogs by an intravital pencil lens-probe videomicroscope. Kidney Int 2001; 60: 364-369.
19. Ohta K, Shimazu K, Komatsumoto S, Araki N, Shibata M, Fukuuchi Y: Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors. Neuroreport 1994; 5: 766-768.
20. Arakawa K, Suzuki H, Naitoh M, et al: Role of adenosine in the renal responses to contrast medium. Kidney Int 1996; 49: 1199-1206.
21. Murakami M, Matsuda H, Kubota E, et al: Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney. Kidney Int 1997; 63 (Suppl 5): S132-S135.
22. Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T: Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 1996; 19: 31-36.
23. Kimura K, Nagai R, Sakai T, et al: Diversity and variability of smooth muscle phenotypes of renal arterioles as revealed by myosin heavy isoform expression. Kidney Int 1995; 48: 372-382.
24. Mattson DL, Roman RJ: Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Am J Physiol 1991; 260: F670-F679.
25. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA: Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993; 91: 2012-2019.
26. Takenaka T, Suzuki H, Kanno Y, et al: Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. J Clin Invest 1997; 100: 2107-2114.
27. Harrison-Bernard LM, Carmines PK: Impact of cyclooxygenase blockade on juxtamedullary microvascular responses to angiotensin II in rat kidney. Clin Exp Pharmacol Physiol 1995; 22: 732-738.
28. Kohagura K, Arima S, Endo Y, et al: Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles. Hypertens Res 2001; 24: 551-557.
29. Tokuyama H, Hayashi K, Matsuda H, et al: Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia. Am J Physiol 2002; 282: F859-F865.
30. Tang L, Loutzenhiser K, Loutzenhiser R: Biphasic actions of prostaglandin E2 on the renal afferent arteriole-role of EP3 and EP4 receptors. Circ Res 2000; 86: 663-670.
31. Zou AP, Wu F, Cowley A Jr: Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 1998; 31: 271-276.
32. Ohishi K, Carmines PK, Inscho EW, Navar LG: EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol 1992; 263: F900-F906.
33. Hayashi K, Epstein M, Loutzenhiser R: Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res 1989; 65: 1475-1484.